{
    "2020-11-05": [
        [
            {
                "time": "",
                "original_text": "一周亏损30%：先声药业，港股的“韭菜收割机” 亏损",
                "features": {
                    "keywords": [
                        "先声药业",
                        "港股",
                        "韭菜收割机",
                        "亏损"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "集采下的思索与机会",
                "features": {
                    "keywords": [
                        "集采",
                        "思索",
                        "机会"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020Q3持仓分析：医药仓位有所回落 紧握核心资产",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2020Q3",
                        "持仓分析",
                        "核心资产"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "2020福布斯中国富豪榜出炉！养生堂创始人、万泰生物实际控制人钟睒睒跻身第三名",
                "features": {
                    "keywords": [
                        "福布斯",
                        "中国富豪榜",
                        "钟睒睒",
                        "万泰生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "福布斯：中国400位富豪总财富已超2万亿美元，医药行业成“造富机器”",
                "features": {
                    "keywords": [
                        "福布斯",
                        "中国富豪",
                        "医药行业",
                        "造富机器"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "人民金融·创新药指数涨1.2% | 我国新冠检测试剂和疫苗研发取得突破，多个创新药获批美国临床",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "新冠检测",
                        "疫苗研发",
                        "美国临床"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业上市公司2020年三季报小结：疫情影响逐渐消退 关注高成长龙头+细分冠军",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "疫情影响",
                        "高成长龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股融资融券日报：两融余额增加53.2亿元（11月4日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国泰君安11月医药行业投资策略：业绩良性恢复 静待政策落地（附股）",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "医药行业",
                        "投资策略",
                        "政策落地"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}